Google plans to release new ‘open’ AI models for drug discovery
During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...
DMR News on MSN2d
Google Unveils Open AI Models for Accelerating Drug Discovery
During a health-focused event in New York on Tuesday, Google announced the development of a new collection of “open” AI ...
Forbes25d
InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug
In this week’s edition of InnovationRx, we look at Eli Lilly ... AI biotech startup Genesis Therapeutics entered an agreement with pharmaceutical company Incyte to use Genesis’ AI drug ...
pharmaphorum7d
Lilly takes AI-selected Olumiant into phase 3 for COVID-19
Eli Lilly has enrolled the first patient into a phase 3 trial that is seeking to repurpose arthritis drug Olumiant as a treatment for people with COVID-19. The 400-patient trial will test Olumiant ...
Eli Lilly: Growth With Higher Margins
Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...
STAT25d
Eli Lilly announces $27 billion investment in U.S. drug manufacturing sites
WASHINGTON — Eli Lilly plans to spend $27 billion to build four new drug manufacturing sites in the United States, the company announced Wednesday, at a time when the Trump administration is ...
Eli Lilly plans to launch weight-loss drug in emerging markets this year
Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and ...